Similar articles

• [Prolonged succinylcholine-induced apnoea associated with cholinesterase silent plasma variant].

  Ceppa F, Kenane N, Chellak S, Bigaillon C, Burnat P. Ceppa F, et al. Ann Fr Anesth Reanim. 2005 Apr;24(4):425-7. doi: 10.1016/j.annfar.2004.12.029. Ann Fr Anesth Reanim. 2005. PMID: 15826794 French.
• Suxamethonium and mivacurium sensitivity from pregnancy-induced plasma cholinesterase deficiency.

  Davies P, Landy M. Davies P, et al. Anaesthesia. 1998 Nov;53(11):1109-11. doi: 10.1046/j.1365-2044.1998.00581.x. Anaesthesia. 1998. PMID: 10023281
• Patient information sheet for plasma cholinesterase deficiency.

  Dillon D, Lee P. Dillon D, et al. Anaesthesia. 2013 Oct;68(10):1085. doi: 10.1111/anae.12429. Anaesthesia. 2013. PMID: 24047308 No abstract available.
• Plasma cholinesterase deficiency.

  Dell DD, Kehoe C. Dell DD, et al. J Perianesth Nurs. 1996 Oct;11(5):304-8. doi: 10.1016/s1089-9472(96)90086-6. J Perianesth Nurs. 1996. PMID: 8970294 Review.
• PharmGKB summary: succinylcholine pathway, pharmacokinetics/pharmacodynamics.

  Alvarellos ML, McDonagh EM, Patel S, McLeod HL, Altman RB, Klein TE. Alvarellos ML, et al. Pharmacogenet Genomics. 2015 Dec;25(12):622-30. doi: 10.1097/FPC.0000000000000170. Pharmacogenet Genomics. 2015. PMID: 26398623 Free PMC article. Review. No abstract available.